Clorox's Sluggish Consumption Trends to Be Partially Offset by New Product Launch, Says RBC

MT Newswires Live01-31 04:02

Clorox (CLX) is poised to meet expectations in its second-quarter results, with low single digit organic sales declines, as weak consumption is seen to be partially offset by new product distribution, RBC said Friday.

Following the company's reaffirmation of its fiscal 2026 outlook last week, the investment firm does not expect any major guidance changes in second-quarter results due on Feb. 3.

Consumption trends for the hygiene products maker have worsened year-on-year, with around 3.5% decline in its US business, dragged down by Health and Wellness segment.

However, the brokerage is pinning hopes on Clorox's new allergen-focused product launch, which is to benefit Q2 results through initial distribution.

Investor reaction has remained muted to the company's $2.25 billion acquisition of GOJO Industries, announced this month, as the market had been expecting Clorox to acquire a smaller, higher growth asset, it added.

RBC maintained a sector perform rating and price target of $142.

Shares of Clorox rose around 2.4% in recent Friday trading.

Price: 112.25, Change: +2.55, Percent Change: +2.32

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment